Cibc Private Wealth Group, LLC Moderna, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $53.9 Billion
- Q3 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 4,067 shares of MRNA stock, worth $163,208. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,067
Previous 4,991
18.51%
Holding current value
$163,208
Previous $592,000
54.22%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding MRNA
# of Institutions
953Shares Held
240MCall Options Held
10.6MPut Options Held
18.7M-
Baillie Gifford & CO42.5MShares$1.7 Billion2.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.2MShares$1.61 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.03 Billion0.07% of portfolio
-
State Street Corp Boston, MA16.8MShares$676 Million0.05% of portfolio
-
Theleme Partners LLP London, X07.23MShares$290 Million28.47% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $15.7B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...